Spinal dis-inhibition in inflammatory pain.
Inflammatory diseases and neuropathic insults trigger signaling cascades, which frequently lead to intense and long-lasting pain syndromes in affected patients. Such pain syndromes are characterized not only by an increased sensitivity to painful stimuli (hyperalgesia), but also by a qualitative change in the sensory perception of other, tactile stimuli (allodynia) and the occurrence of spontaneous pain in the absence of any sensory input. Long-term potentiation (LTP)-like changes in synaptic transmission between nociceptive C-fibers and spino-periaqueductal grey projection neurons as well as a loss of inhibitory control by GABAergic and glycinergic spinal dorsal horn neurons have repeatedly been proposed as underlying principles. While considerable evidence supports a significant contribution of C-fiber LTP to hyperalgesia, such monosynaptic plasticity cannot explain the occurrence of allodynia and spontaneous pain. In this review, we focus on mechanisms of synaptic dis-inhibition in inflammatory pain and propose that pathologically heightened pain sensitivity can be reversed by restoring synaptic inhibition with drugs that target specific spinal GABAA receptor subtypes.
Zeilhofer
Hanns Ulrich
HU
Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. zeilhofer@pharma.uzh.ch <zeilhofer@pharma.uzh.ch>
Zeilhofer
Ulrike B
UB
D000818:Animals; D006801:Humans; D007249:Inflammation / Q000150:complications; D008954:Models, Biological; D009433:Neural Inhibition; D010146:Pain / Q000209:etiology / Q000473:pathology*; D013116:Spinal Cord / Q000473:pathology / Q000503:physiopathology*; D013569:Synapses / Q000502:physiology